...
首页> 外文期刊>International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group >Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients
【24h】

Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients

机译:高尺寸复发性乳腺癌的高次乳腺癌,无接触的接触水过滤的红外眠 - 一种热疗:73例患者的回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Evaluation of the efficacy and toxicity of a new setup of thermographically controlled water-filtered infra-red-A (wIRA) superficial hyperthermia (HT) combined with hypofractionated re-irradiation (re-RT) to treat large-sized breast cancer recurrences.Methods: Records of 73 heavily pre-irradiated patients with 103 treatment regions, treated from September 2009 to July 2015 were retrospectively analysed. Sixty-four patients with macroscopic disease were treated with 94 regions including 46 patients with lymphangiosis carcinomatosa. Hypofractionated RT consisted of 4Gy once per week up to a total dose of 20Gy delivered within 1-4min after wIRA-HT. Heating of tumour nodules and diffusely spreading cancer lesions was performed under real-time thermographic temperature monitoring, maintaining the maximum skin temperature in the ROI between 42 degrees C and 43 degrees C, achieving intratumoural temperatures up to a depth of 2cm between 39.5 degrees C and 42 degrees C. Seventeen patients received re-re-irradiation (re-re-RT) using the same HT/RT-treatment schedule.Results: Response rates in patients with macroscopic disease: 61% CR, 33% PR, 5% NC and 1% PD. Local control throughout life time after CR of macroscopic disease: 59%. All nine patients with microscopic disease had CR and local control throughout lifetime. Only grade 1 toxicities were observed.Conclusions: Application of thermographically controlled wIRA-HT combined with extremely low-dose re-irradiation provides good local control throughout lifetime of heavily pre-treated breast cancer recurrences. The twin wIRA radiator provides a sufficiently homogeneous heat deposition for the treatment of larger areas. The time lag between HT and re-RT is substantially reduced. The possibility of re-re-RT opens new therapeutic options for the future.
机译:目的:评估热量控制的水过滤的红外线 - 红-A(WIRA)浅色热化(HT)的新设置的疗效和毒性联合低辐射再辐射(RE-RT)以治疗大型乳腺癌复发。方法:回顾性分析了2009年9月至2015年7月的73名患有103例治疗区域的73名患者的记录。用94个地区治疗64例宏观疾病患者,其中包括46例淋巴管症癌癌。低速缓解RT由4Gy每周组成,在WIRA-HT后1-4分钟内输送的总剂量20g。在实时热成像监测下进行肿瘤结节和弥漫性扩散癌病变,将ROI的最大皮肤温度保持在42℃和43摄氏度之间,在39.5摄氏度之间实现高度为2cm的深度。 42摄氏度,17名患者使用相同的HT / RT治疗时间表接受重新辐照(再重新RT)。结果:宏观疾病患者的反应率:61%Cr,33%Pr,5%NC和1%的pd。在宏观疾病的CR后局部使用局部控制:59%。所有9例微观疾病患者都有CR和局部控制。仅观察到1级毒性。结论:热量控制的Wia-HT合并与极低剂量的再辐射相结合,提供良好的局部控制,其终身预处理的乳腺癌复发。双WIRA散热器提供足够均匀的热沉积,用于治疗较大区域。 HT和RT-R之间的时间滞后显着减少。重新RT的可能性开启了未来的新治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号